An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen (original) (raw)

References

• Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ . (2003). Am J Clin Pathol 120: 725–731.
• Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ et al. (1995). J Steroid Biochem Mol Biol 52: 459–467.
• Buchanan G, Birrell SN, Peters AA, Bianco-Miotto T, Ramsay K, Cops EJ et al. (2005). Cancer Res 65: 8487–8496.
• Carsol JL, Gingras S, Simard J . (2002). Mol Endocrinol 16: 1696–1710.
• Cato AC, Nestl A, Mink S . (2002). Sci STKE 2002: RE9.
• Cunliffe HE, Ringner M, Bilke S, Walker RL, Cheung JM, Chen Y et al. (2003). Cancer Res 63: 7158–7166.
• de Hoon MJ, Imoto S, Nolan J, Miyano S . (2004). Bioinformatics 20: 1453–1454.
• DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M et al. (1996). Nat Genet 14: 457–460.
• Dhanasekaran SM, Dash A, Yu J, Maine IP, Laxman B, Tomlins SA et al. (2005). FASEB J 19: 243–245.
• Dickson C, Spencer-Dene B, Dillon C, Fantl V . (2000). Breast Cancer Res 2: 191–196.
• Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D et al. (2005). Oncogene 24: 4660–4671.
• Gatalica Z . (1997). Pathol Res Pract 193: 753–758.
• Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP et al. (1999). Science 286: 531–537.
• Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ et al. (2003). N Engl J Med 349: 1793–1802.
• Greeve MA, Allan RK, Harvey JM, Bentel JM . (2004). J Mol Endocrinol 32: 793–810.
• Gruber CJ, Tschugguel W, Schneeberger C, Huber JC . (2002). N Engl J Med 346: 340–352.
• Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A et al. (2001). Cancer Res 61: 5979–5984.
• Hall RE, Aspinall JO, Horsfall DJ, Birrell SN, Bentel JM, Sutherland RL et al. (1996). Br J Cancer 74: 1175–1180.
• Hall RE, Birrell SN, Tilley WD, Sutherland RL . (1994). Eur J Cancer 30A: 484–490.
• Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L et al. (2004). Am J Pathol 164: 217–227.
• Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF et al. (2005). Lancet 365: 60–62.
• Isola JJ . (1993). J Pathol 170: 31–35.
• Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. (2005). CA Cancer J Clin 55: 10–30.
• Koziczak M, Hynes NE . (2004). J Biol Chem 279: 50004–50011.
• Koziczak M, Holbro T, Hynes NE . (2004). Oncogene 23: 3501–3508.
• Lacroix M, Leclercq G . (2004). Breast Cancer Res Treat 83: 249–289.
• Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguere V . (2005). Proc Natl Acad Sci USA 102: 11651–11656.
• Lal P, Tan LK, Chen B . (2005). Am J Clin Pathol 123: 541–546.
• Lippman M, Bolan G, Huff K . (1976). Cancer Res 36: 4610–4618.
• Losel RM, Falkenstein E, Feuring M, Schultz A, Tillmann HC, Rossol-Haseroth K et al. (2003). Physiol Rev 83: 965–1016.
• Matsuo K, Fukutomi T, Hasegawa T, Akashi-Tanaka S, Nanasawa T, Tsuda H . (2002). Breast Cancer 9: 43–49.
• Mayfield S, Vaughn JP, Kute TE . (2001). Breast Cancer Res Treat 70: 123–129.
• McKenna NJ, O’Malley BW . (2002). Endocrinology 143: 2461–2465.
• Mellinghoff IK, Vivanco I, Kwon A, Tran C, Wongvipat J, Sawyers CL . (2004). Cancer Cell 6: 517–527.
• Miller WR, Telford J, Dixon JM, Shivas AA . (1985). Breast Cancer Res Treat 5: 67–73.
• Mosmann T . (1983). J Immunol Methods 65: 55–63.
• Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A et al. (2001). J Clin Oncol 19: 2596–2606.
• Nagahata T, Onda M, Emi M, Nagai H, Tsumagari K, Fujimoto T et al. (2004). Cancer Sci 95: 218–225.
• Nantermet PV, Masarachia P, Gentile MA, Pennypacker B, Xu J, Holder D et al. (2005). Endocrinology 146: 564–578.
• Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J et al. (2002). Proc Natl Acad Sci USA 99: 11890–11895.
• Osborne CK, Wakeling A, Nicholson RI . (2004). Br J Cancer 90 (Suppl 1): S2–S6.
• Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. (2000). Nature 406: 747–752.
• Pusztai L, Ayers M, Stec J, Clark E, Hess K, Stivers D et al. (2003). Clin Cancer Res 9: 2406–2415.
• Rossi S, Graner E, Febbo P, Weinstein L, Bhattacharya N, Onody T et al. (2003). Mol Cancer Res 1: 707–715.
• Sapp M, Malik A, Hanna W . (2003). Breast J 9: 335–336.
• Shao D, Lazar MA . (1999). J Clin Invest 103: 1617–1618.
• Shurbaji MS, Kalbfleisch JH, Thurmond TS . (1996). Hum Pathol 27: 917–921.
• Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A et al. (2001). N Engl J Med 344: 783–792.
• Smith IE, Dowsett M . (2003). N Engl J Med 348: 2431–2442.
• Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al. (2003). Proc Natl Acad Sci USA 100: 8418–8423.
• Steketee K, Ziel-van der Made AC, van der Korput HA, Houtsmuller AB, Trapman J . (2004). J Mol Endocrinol 33: 477–491.
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. (2005). Proc Natl Acad Sci USA 102: 15545–15550.
• Tang S, Han H, Bajic VB . (2004). Nucleic Acids Res 32: D533–D536.
• Tobias JS . (2004). Ann Oncol 15: 1738–1747.
• van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al. (2002). Nature 415: 530–536.
• Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F et al. (2005). Lancet 365: 671–679.
• West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R et al. (2001). Proc Natl Acad Sci USA 98: 11462–11467.
• Wilson CA, Dering J . (2004). Breast Cancer Res 6: 192–200.
• Wong YC, Xie B . (2001). Ital J Anat Embryol 106: 111–125.
• Yakes FM, Chinratanalab W, Ritter CA, King W, Seelig S, Arteaga CL . (2002). Cancer Res 62: 4132–4141.

Download references